ENBREL
Pronunciation: et-a-NER-sept

What it isTNF receptor fusion protein; rheumatoid arthritis, psoriasis and ankylosing spondylitis.
Why this oneShorter half-life than the antibody TNF blockers, so it clears faster if infection develops.
What limits itDoes NOT work in inflammatory bowel disease, unlike the antibody agents — a common misassumption. Screen for tuberculosis and hepatitis B.
Legacy pregnancy categoryC
Defining liabilitySerious infection, cytopenias, hepatic injury and malignancy risk require laboratory and clinical monitoring.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis | adult | 50 mg weekly | 50 mg weekly | 50 mg weekly |
| Plaque psoriasis | adult | 50 mg twice weekly x3 months | 50 mg weekly | 50 mg twice weekly (starting) |
| Plaque psoriasis or juvenile idiopathic arthritis | pediatric | 0.8 mg/kg weekly | 0.8 mg/kg weekly | 50 mg weekly |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Registry data do not reliably support association with major birth defects; consider risks/benefits.
Lactation Present in low levels in human milk, minimally absorbed by breastfed infant.
| Strength | #/mo | generic $/unit | brand $/unit | CostPlus | |
|---|---|---|---|---|---|
| 50 mg/mL | inj | per unit | — | $2080.99/mL | not offered |
Generic entry2029 est. (biosimilar)
Open Etanercept in the interactive console ↗

Open Etanercept in the interactive console ↗